NASDAQ
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Open
$0.73
Previous Close
$0.91
Day High
$0.91
Day Low
$0.73
52 Week High
$3.33
52 Week Low
$0.23
No price data available for this timeframe.